A citation-based method for searching scientific literature

Tuya Pal, Erin Rocchio, Ana Garcia, Desiree Rivers, Susan Vadaparampil. Genet Test Mol Biomarkers 2011
Times Cited: 19







List of co-cited articles
120 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
288
42

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
63
36

Making effective use of tumor registries for cancer survivorship research.
A T Pakilit, B A Kahn, L Petersen, L S Abraham, G A Greendale, P A Ganz. Cancer 2001
48
26

Patient perspectives on research recruitment through cancer registries.
Laura M Beskow, Robert S Sandler, Robert C Millikan, Morris Weinberger. Cancer Causes Control 2005
27
26

Breast cancer in African-American women.
Lisa A Newman. Oncologist 2005
124
26

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
155
26

Using a population-based cancer registry for recruitment in a pilot cancer control study.
P A Newcomb, R R Love, J L Phillips, B J Buckmaster. Prev Med 1990
20
21

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
227
21


Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
Kathleen E Malone, Janet R Daling, David R Doody, Li Hsu, Leslie Bernstein, Ralph J Coates, Polly A Marchbanks, Michael S Simon, Jill A McDonald, Sandra A Norman,[...]. Cancer Res 2006
214
21

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
111
21

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
21

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
21

Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
Tuya Pal, Devon Bonner, Jongphil Kim, Alvaro N A Monteiro, Lisa Kessler, Robert Royer, Steven A Narod, Susan T Vadaparampil. Breast J 2013
27
21

Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial.
Rebecca G Simmons, Yuan-Chin Amy Lee, Antoinette M Stroup, Sandra L Edwards, Amy Rogers, Christopher Johnson, Charles L Wiggins, Deirdre A Hill, Rosemary D Cress, Jan Lowery,[...]. Trials 2013
16
25

Genetic testing in young women with breast cancer: results from a Web-based survey.
K J Ruddy, S Gelber, J Shin, J E Garber, R Rosenberg, M Przypysny, A H Partridge. Ann Oncol 2010
17
17

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
298
15

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
113
15


Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
187
15

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
78
15

Research recruitment through US central cancer registries: balancing privacy and scientific issues.
Laura M Beskow, Robert S Sandler, Morris Weinberger. Am J Public Health 2006
52
15

Testing three different cancer genetics registry recruitment methods with Hispanic cancer patients and their family members previously registered in local cancer registries in Texas.
Amelie G Ramirez, Alexander R Miller, Kipling Gallion, Sandra San Miguel de Majors, Patricia Chalela, Sandra García Arámburo. Community Genet 2008
15
20


Development of a brochure for increasing awareness of inherited breast cancer in black women.
Susan T Vadaparampil, Gwendolyn P Quinn, Anxhela Gjyshi, Tuya Pal. Genet Test Mol Biomarkers 2011
10
30


Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009
190
15

Earlier age of onset of BRCA mutation-related cancers in subsequent generations.
Jennifer K Litton, Kaylene Ready, Huiqin Chen, Angelica Gutierrez-Barrera, Carol J Etzel, Funda Meric-Bernstam, Ana M Gonzalez-Angulo, Huong Le-Petross, Karen Lu, Gabriel N Hortobagyi,[...]. Cancer 2012
46
15

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.
Lisa R Susswein, Cécile Skrzynia, Leslie A Lange, Jessica K Booker, Mark L Graham, James P Evans. J Clin Oncol 2008
43
15

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
15

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
224
15

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
246
15

Prevention and management of hereditary breast cancer.
Steven A Narod, Kenneth Offit. J Clin Oncol 2005
107
15

BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.
Tuya Pal, Jenny Permuth-Wey, Tricia Holtje, Rebecca Sutphen. Cancer Epidemiol Biomarkers Prev 2004
42
15

Recruiting African American women to participate in hereditary breast cancer research.
Chanita Hughes Halbert, Kiyona Brewster, Aliya Collier, Chachira Smith, Lisa Kessler, Benita Weathers, Jill E Stopfer, Susan Domchek, E Paul Wileyto. J Clin Oncol 2005
40
15

Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer.
Marijana Lijovic, Susan R Davis, Pam Fradkin, Maria La China, Helen Farrugia, Rory Wolfe, Robin J Bell. BMC Cancer 2008
33
15

Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
71
15

Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.
Anne Marie McCarthy, Mirar Bristol, Tracey Fredricks, Lache Wilkins, Irene Roelfsema, Kaijun Liao, Judy A Shea, Peter Groeneveld, Susan M Domchek, Katrina Armstrong. Cancer 2013
16
18

Racial and ethnic disparities in awareness of genetic testing for cancer risk.
José A Pagán, Dejun Su, Lifeng Li, Katrina Armstrong, David A Asch. Am J Prev Med 2009
68
15


Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
157
15

Participation rates in a case-control study: the impact of age, race, and race of interviewer.
P G Moorman, B Newman, R C Millikan, C K Tse, D P Sandler. Ann Epidemiol 1999
151
15

Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for Black women.
Jennifer Permuth-Wey, Susan Vadaparampil, Alnecia Rumphs, Anita Yeomans Kinney, Tuya Pal. Am J Med Genet A 2010
16
18

Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.
Melissa Y Carpentier, Jasmin A Tiro, Lara S Savas, L Kay Bartholomew, Trisha V Melhado, Sharon P Coan, Keith E Argenbright, Sally W Vernon. J Cancer Surviv 2013
11
27

The rationale, design, and implementation of the American Cancer Society's studies of cancer survivors.
Tenbroeck Smith, Kevin D Stein, C Christina Mehta, Chiewkwei Kaw, James L Kepner, Trent Buskirk, Jeremy Stafford, Frank Baker. Cancer 2007
153
15

Identification and referral of families at high risk for cancer susceptibility.
Kevin M Sweet, Terry L Bradley, Judith A Westman. J Clin Oncol 2002
130
10

"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.
Claire E Wakefield, Paboda Ratnayake, Bettina Meiser, Graeme Suthers, Melanie A Price, Jessica Duffy, Kathy Tucker. Genet Test Mol Biomarkers 2011
18
11

What motivates interest in attending a familial cancer genetics clinic?
L Fraser, S Bramald, C Chapman, C Chu, V Cornelius, F Douglas, A Lucassen, A Nehammer, S Sutton, M Trivella,[...]. Fam Cancer 2003
26
10

Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
85
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.